Effectiveness of topical gentamicin in preventing surgical site infections during hernia mesh repair: experience from developing countries
Hernia · 2025
DOI: 10.1007/s10029-025-03372-1 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Hernia, 2025. Verfasst von Mohamed Daffalla-Awadalla Gismalla und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Faculty of Behari, Khartom North, Sudan. mohadaff22@gmail.com. Hauptthemen laut MEDLINE: Gentamicins, Surgical Wound Infection, Surgical Mesh, Herniorrhaphy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 14 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Recently, mesh repair has become a standard treatment for inguinal and ventral hernial disease worldwide. Consequently, mesh-related complications have increased, especially superficial site infections. This study aimed to determine the role of topical gentamicin in reducing superficial surgical site infection. METHODS: This was a prospective, cross-sectional, comparative, hospital-based study conducted between July 2022 and March 2023. Patients who underwent elective mesh repair for inguinal or para-umbilical hernia were reviewed. Participants were divided into two groups: the control group (G1), which did not receive topical gentamicin, and the study group (G2), which received topical gentamicin. The surgical site was examined on the 1st, 7th, and 30th postoperative days for signs of infection according to the definitions provided by the Centers for Disease Control Control. RESULTS: A total of 197 fulfilled our inclusion criteria. The infection rate in all study participants (N = 197) was 4.5%. A total of (n = 9) 4.5% SSIs occurred among the 197 patients, with 3.5% (n = 7) in G1 and 1% (n = 2) in G2 (Table 2). Four patients (2.0%) developed a hematoma, all of whom had an inguinal hernia. Three of these patients developed SSI, with two in G1 and one in G2 All infections observed were superficial surgical infections (SSI); No statistical significance was ruled out. CONCLUSION: Our study sheds light on the use of topical gentamicin in preventing early SSIs following hernia and para-umbilical mesh repair surgery in developing countries. There are no significant differences when using topical gentamicin to prevent surgical site infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Faculty of Behari, Khartom North, Sudan. mohadaff22@gmail.com.
- University of Gezira Faculty of Medicine, Wad Madani, Sudan. mohadaff22@gmail.com.
- Department of Surgery, Dongola Specialized Hospital, Federal Ministry of Health, Dongola, Sudan.
- Department of Surgery, Faculty of Medicine, Al-Baha University, Al Aqiq, Saudi Arabia.
ORCID-Profile: Mohamed Daffalla-Awadalla Gismalla
Zitieren
APA
Gismalla, M. D., Ibrahim, M. M. A., Mahmoud, M. A., & Alamalhuda, A. A. H. (2025). Effectiveness of topical gentamicin in preventing surgical site infections during hernia mesh repair: experience from developing countries. Hernia. https://doi.org/10.1007/s10029-025-03372-1
Vancouver
Gismalla MD, Ibrahim MMA, Mahmoud MA, Alamalhuda AAH. Effectiveness of topical gentamicin in preventing surgical site infections during hernia mesh repair: experience from developing countries. Hernia. 2025. doi:10.1007/s10029-025-03372-1
BibTeX
@article{Gismalla2025,
author = {Gismalla, Mohamed Daffalla-Awadalla and Ibrahim, Monzer Mohammed Abdallah and Mahmoud, Mohammed Abdelhaleem and Alamalhuda, Alsidiek Abdelazeem Hassan},
title = {Effectiveness of topical gentamicin in preventing surgical site infections during hernia mesh repair: experience from developing countries},
journal = {Hernia},
year = {2025},
doi = {10.1007/s10029-025-03372-1}
}
EUVIMED